Essential role of NAT1/p97/DAP5 in embryonic differentiation and the retinoic acid pathway

EMBO Journal

Volumn 19, Issue 20, 2000, Pages 5533-5541

  Yamanaka, Shinya ^a   Zhang, Xiao Ying ^b   Maeda, Mitsuyo ^b   Miura, Katsuyuki ^b   Wang, Shelley ^c   Farese, Robert V ^c   Iwao, Hiroshi ^b   Innerarity, Thomas L ^c,d  

^a NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

eIF4G; ES cell; Knockout mouse; Teratoma; Translation

Indexed keywords

DAP5 PROTEIN; INITIATION FACTOR; NAT1 PROTEIN; PROTEIN; PROTEIN P21; PROTEIN P97; RETINOIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL CYCLE PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; EUKARYOTE; GENE EXPRESSION; GENETIC TRANSFECTION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; RNA TRANSLATION; SEQUENCE HOMOLOGY; TERATOMA; TRANSLATION REGULATION;

ANIMALIA; EUKARYOTA; MAMMALIA;

EID: 0034676036     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/19.20.5533     Document Type: Article

References (48)

1. Translation initiation factor eIF-4γ is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma
2. A decade of molecular biology of retinoic acid receptors
3. Teratoma and teratocarcinoma in experimental animals
4. The acute promyelocytic leukemia PML-RARα protein induces hepatic preneoplastic and neoplastic lesions in transgenic mice
5. eIF4E expression in tumors: Its possible role in progression of malignancies
6. Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology
7. Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex
8. Identification and quantitation of levels of protein synthesis initiation factors in crude HeLa cell lysates by two-dimensional polyacrylamide gel electrophoresis
9. Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggest a role in translational control. Heat shock effects on eIF-4F
10. Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eukaryotic initiation factor 3 and a cap binding protein complex
11. Malignant transformation by overproduction of translation initiation factor eIF4G
12. eIF4 initiation factors: Effectors of mRNA recruitment to ribosomes and regulators of translation
13. A novel form of DAP5 protein accumulates in apoptotic cells as a result of caspase cleavage and internal ribosome entry site-mediated translation
14. eIF4G: A multipurpose ribosome adapter?
15. A new translational regulator with homology to eukaryotic translation initiation factor 4G
16. A newly identified N-terminal amino acid sequence of human eIF4G binds poly(A)-binding protein and functions in poly(A)-dependent translation
17. Biosynthesis of apolipoprotein B48-containing lipoproteins. Regulation by novel post-transcriptional mechanisms
18. Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation
19. Protein synthesis initiation factor 4G
20. Mapping of functional domains in eukaryotic protein synthesis initiation factor 4G (eIF4G) with picornaviral proteases. Implications for cap-dependent and cap-independent translational initiation
21. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap
22. DAP-5, a novel homolog of eukaryotic translation initiation factor 4G isolated as a putative modulator of γ interferon-induced programmed cell death
23. PHAS-I as a link between mitogen-activated protein kinase and translation initiation
24. Origins and targets of translational control
25. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA
26. Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: Evidence suggesting multiple cholesterol esterification enzymes in mammals
27. The pathway and mechanism of eukaryotic protein synthesis
28. Development of a highly efficient expression cDNA cloning system: Application to oncogene isolation
29. eIF4G: Translation's mystery factor begins to yield its secrets
30. Production of homozygous mutant ES cells with a single targeting construct
31. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4
32. Embryonic retinoic acid synthesis is essential for early mouse post-implantation development
33. Retinoic acid synthesis and hindbrain patterning in the mouse embryo
34. A retinoic acid-triggered cascade of HOXB1 gene activation
35. The C-terminal domain of eukaryotic protein synthesis initiation factor (eIF) 4G is sufficient to support cap-independent translation in the absence of eIF4E
36. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells
37. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function
38. Functional dissection of eukaryotic initiation factor 4F: The 4A subunit and the central domain of the 4G subunit are sufficient to mediate internal entry of 43S preinitiation complexes
39. Retinoic acid represses Oct-3/4 gene expression through several retinoic acid-responsive elements located in the promoter-enhancer region
40. Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E
41. cDNA cloning, expression analysis, and chromosomal localization of a gene with high homology to wheat eIF-(iso)4F and mammalian eIF-4G
42. The induction of differentiation in teratocarcinoma stem cells by retinoic acid
43. Cap recap: The involvement of eIF-4F in regulating gene expression
44. The role of the 5' untranslated region of an mRNA in translation regulation during development
45. Translational control of growth factor and proto-oncogene expression
46. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals
47. A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme
48. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARα and T18 oncoproteins